tirzepatide phase 2 obesity for Treatment and Diabetes Prevention Frontiers | Tirzepatide vs. semaglutide

Cell Mol Life Sci 78(13):53035324

The research team investigated whether GLP-1 RAs are associated with a reduced incidence of cirrhosis and related complications in patients with MASLD and diabetes, compared to dipeptidyl peptidase 4 inhibitors (DPP-4i)

,

Predictability Each peptide has a defined role, such as reducing inflammation, stimulating angiogenesis, or supporting neurons

Two ways to get started: Two ways to get started: Option 1: Start with optional bloodwork Establish your baseline with our comprehensive 100+ biomarker panel, then access treatments that target your specific optimization opportunities if you choose